EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $649,551 | +2.8% | 62,698 | +108.4% | 0.02% | -18.2% |
| Q3 2022 | $632,000 | +29.8% | 30,089 | +91.9% | 0.02% | 0.0% |
| Q2 2022 | $487,000 | -75.2% | 15,677 | -67.2% | 0.02% | -76.1% |
| Q1 2022 | $1,964,000 | +180.2% | 47,836 | +241.7% | 0.09% | +64.3% |
| Q3 2021 | $701,000 | +91.5% | 14,000 | +255.1% | 0.06% | +64.7% |
| Q1 2021 | $366,000 | -79.4% | 3,942 | -77.1% | 0.03% | -70.2% |
| Q3 2020 | $1,779,000 | +246.8% | 17,221 | +94.3% | 0.11% | +208.1% |
| Q1 2020 | $513,000 | +3.8% | 8,861 | -16.7% | 0.04% | -31.5% |
| Q4 2017 | $494,000 | +145.8% | 10,635 | +74.0% | 0.05% | +68.8% |
| Q4 2016 | $201,000 | -49.2% | 6,111 | -43.9% | 0.03% | -30.4% |
| Q1 2016 | $396,000 | +39.9% | 10,900 | +26.7% | 0.05% | +43.8% |
| Q2 2015 | $283,000 | -69.4% | 8,600 | -73.3% | 0.03% | -66.3% |
| Q1 2015 | $926,000 | – | 32,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |